share_log

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Dudley Robert Michael

SEC announcement ·  May 19, 2023 20:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more